NCT04504487 is a NA clinical trial of Drain Removal in Liver Transplant, sponsored by Institute of Liver and Biliary Sciences, India.

Who is sponsoring NCT04504487?

NCT04504487 is sponsored by Institute of Liver and Biliary Sciences, India.

What drugs are being tested in NCT04504487?

Interventions in NCT04504487: Drain Removal.

What condition does NCT04504487 study?

NCT04504487 studies Liver Transplant.

Is NCT04504487 still recruiting?

NCT04504487 is currently completed. Last updated 13 May 2022.

Last reviewed 2022-05-13 · How we verify

NCT04504487

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Versus Routine Drain Removal After Live Liver Donor Hepatectomy

Completed NA Last updated 13 May 2022

What this trial tests

NA trial testing Drain Removal in Liver Transplant in 108 participants. Completed in 25 February 2022.

Timeline

28 January 2021

Primary endpoint
25 February 2022

25 February 2022

Quick facts

Lead sponsor	Institute of Liver and Biliary Sciences, India
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	108
Start date	28 January 2021
Primary completion	25 February 2022
Estimated completion	25 February 2022
Sites	1 location across India

Drugs / interventions tested

Drain Removal

Conditions studied

Liver Transplant — all drugs for Liver Transplant →

Sponsor

Institute of Liver and Biliary Sciences, India

Who can join

Eligibility, any sex, with Liver Transplant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It's a randomized control trial to compare early drain removal versus standard drain removal after donor hepatectomy in terms of donor outcomes. We will analyse the data and elucidate the safety of early drain removal using 3x3 rule with routine drain removal.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Early drain removal after live liver donor hepatectomy is safe - a randomized controlled pilot study.
Durairaj P, Pamecha V, Mohapatra N, Patil NS, et al · · 2023 · PMID 37670194 · DOI 10.1007/s00423-023-03088-9
Early drain removal after live liver donor hepatectomy is safe - A randomized control trial
Durairaj P, Pamecha V, Mohapatra N, Patil N, et al · · 2022 · DOI 10.21203/rs.3.rs-2141095/v1

Verify or expand the search:

Other recruiting trials for Liver Transplant

Currently open trials in the same condition.

NCT06254248 — Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma · Phase 2 · recruiting
NCT06832189 — EVR and EPO for Liver Transplant Tolerance · Phase 1 · recruiting
NCT07216508 — Liver Transplant CGM · recruiting
NCT07086989 — Cardiovascular Risk in Children With Chronic Conditions Study · recruiting
NCT06813508 — Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH · recruiting

Other Institute of Liver and Biliary Sciences, India trials

Trials by the same sponsor.

NCT07480005 — To Revisit the Yield of Staging Laparoscopy in Hepatopancreatobiliary Malignancies · recruiting
NCT07480057 — Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry · recruiting
NCT07465471 — Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis. · NA · not yet recruiting
NCT07433881 — Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis · not yet recruiting
NCT07422948 — Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04504487 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institute of Liver and Biliary Sciences, India
Last refreshed: 13 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04504487.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing